Critical role of the liver in the induction of systemic inflammation in rats with preascitic cirrhosis

Hepatology

Volumn 52, Issue 6, 2010, Pages 2086-2095

  Úbeda, María ^a,b   Muñoz, Leticia ^a,b   Borrero, María José ^a,b   Díaz, David ^a,b   Francés, Rubén ^b,c   Monserrat, Jorge ^a,b   Lario, Margaret ^a,b   Lledó, Lourdes ^a   Such, José ^b,c   Álvarez Mon, Melchor ^a,b,d   Albillos, Agustín ^a,b,e  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^d HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^e HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; CARBON TETRACHLORIDE; CD134 ANTIGEN; DNA FRAGMENT; NORFLOXACIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL TRANSLOCATION; CELL EXPANSION; CONTROLLED STUDY; ESCHERICHIA COLI; HELPER CELL; IMMUNOCOMPETENT CELL; KLEBSIELLA; LIVER CIRRHOSIS; MALE; MESENTERY LYMPH NODE; MONOCYTE; NONHUMAN; PREASCITIC CIRRHOSIS; PRIORITY JOURNAL; PSEUDOMONAS; RAT;

ANIMALS; CARBON TETRACHLORIDE POISONING; DNA, BACTERIAL; INFLAMMATION; LIVER; LIVER CIRRHOSIS, EXPERIMENTAL; RATS;

EID: 78649598586     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23961     Document Type: Article

References (38)

1. Delves PJ, Roitt IM. The immune system. First of two parts. N Engl J Med 2000; 343: 37-49.
2. Henson PM. Dampening inflammation. Nat Immunol 2005; 6: 1179-1181.
3. Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. HEPATOLOGY 2003; 37: 208-217.
4. Albillos A, de la Hera A, Reyes E, Monserrat J, Muñoz L, Nieto M, et al. Tumour necrosis factor-alpha expression by activated monocytes and altered T-cell homeostasis in ascitic alcoholic cirrhosis: amelioration with norfloxacin. J Hepatol 2004; 40: 624-631.
5. Muñoz L, Albillos A, Nieto M, Reyes E, Lledó L, Monserrat J, et al. Mesenteric Th1 polarization and monocyte TNF-alpha production: first steps to systemic inflammation in rats with cirrhosis. HEPATOLOGY 2005; 42: 411-419.
6. Guarner C, González-Navajas JM, Sánchez E, Soriano G, Francés R, Chiva M, et al. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. HEPATOLOGY 2006; 44: 633-639.
7. Francés R, Zapater P, González-Navajas JM, Muñoz C, Caño R, Moreau R, et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. HEPATOLOGY 2008; 47: 978-985.
8. Wiest R, Das S, Cadelina G, Garcia-Tsao G, Milstien S, Groszmann RJ. Bacterial translocation in cirrhotic rats stimulates eNOS-derived NO production and impairs mesenteric vascular contractility. J Clin Invest 1999; 104: 1223-1233.
9. Kerfoot SM, D'Mello C, Nguyen H, Ajuebor MN, Kubes P, Le T, et al. TNF-alpha-secreting monocytes are recruited into the brain of cholestatic mice. HEPATOLOGY 2006; 43: 154-162.
10. González-Navajas JM, Bellot P, Francés R, Zapater P, Muñoz C, García-Pagán JC, et al. Presence of bacterial-DNA in cirrhosis identifies a subgroup of patients with marked inflammatory response not related to endotoxin. J Hepatol 2008; 48: 61-67.
11. Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 1995; 108: 1835-1841.
12. Clària J, Jiménez W. Experimental models of cirrhosis and ascites. In: Ginés P, Arroyo V, Rodés J, Schrier RW, eds. Ascites and Renal Dysfunction in Liver Disease. Oxford, UK: Blackwell Publishing; 2005: 215-226.
13. Crispe IN. Isolation of mouse intrahepatic lymphocytes. Curr Protoc Immunol 1997;Chapter 3:Unit 3.21.
14. Albillos A, Nieto M, Ubeda M, Muñoz L, Fraile B, Reyes E, et al. The biological response modifier AM3 attenuates the inflammatory cell response and hepatic fibrosis in rats with biliary cirrhosis. Gut 2010; 59: 943-952.
15. Runyon B, Sugano S, Kanel G, Mellencamp M. A rodent model of cirrhosis, ascites, and bacterial peritonitis. Gastroenterology 1991; 100: 489-493.
16. Pérez-Páramo M, Muñoz J, Albillos A, Freile I, Portero F, Santos M, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. HEPATOLOGY 2000; 31: 43-48.
17. Such J, Francés R, Muñoz C, Zapater P, Casellas JA, Cifuentes A, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, non-neutrocytic ascites. HEPATOLOGY 2002; 36: 135-141.
18. Von Andrian UH, Mackay CR. T-cell function and migration. Two sides of the same coin. N Engl J Med 2000; 343: 1020-1034.
19. Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003; 19: 71-82.
20. Steiniger B, Stehling O, Scriba A, Grau V. Monocytes in the rat: phenotype and function during acute allograft rejection. Immunol Rev 2001; 184: 38-44.
21. Yrlid U, Jenkins CD, MacPherson GG. Relationships between distinct blood monocyte subsets and migrating intestinal lymph dendritic cells in vivo under steady-state conditions. J Immunol 2006; 176: 4155-4162.
22. Shirachi M, Sata M, Miyajima I, Tanaka M, Tanikawa K. Liver-associated natural killer activity in cirrhotic rats. Microbiol Immunol 1998; 42: 117-124.
23. Bowen DG, Zen M, Holz L, Davis T, McCaughan GW, Bertolino P. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 2004; 114: 701-712.
24. Tilney NL. Patterns of lymphatic drainage in the adult laboratory rat. J Anat 1971; 109: 369-383.
25. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992; 103: 264-274.
26. Devière J, Content J, Denys C, Vandenbussche P, Schandene L, Wybran J, et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. HEPATOLOGY 1990; 11: 628-634.
27. Albillos A, de-la-Hera A, Alvarez-Mon M. Experimental models of spontaneous bacterial peritonitis.In: Ginés P, Arroyo V, Rodés J, Schrier RW, eds. Ascites and Renal Dysfunction in Liver Disease. Oxford, UK: Blackwell Publishing; 2005: 411-421.
28. Zapater P, Francés R, González-Navajas JM, de la Hoz MA, Moreu R, Pascual S, et al. Serum and ascitic fluid bacterial DNA: a new independent prognostic factor in noninfected patients with cirrhosis. HEPATOLOGY 2008; 48: 1924-1931.
29. Albillos A, de la Hera A. Multifactorial gut barrier failure in cirrhosis: working out the role of probiotics and antioxidants. J Hepatol 2002; 37: 523-526.
30. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002; 20: 709-760.
31. Tamayo RP. Is cirrhosis of the liver experimentally produced by CCl4 an adequate model of human cirrhosis? HEPATOLOGY 1983; 3: 112-120.
32. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 1990; 10: 56-65.
33. Constandinou C, Henderson N, Iredale JP. Modeling liver fibrosis in rodents. Methods Mol Med 2005; 117: 237-250.
34. Iredale JP, Benyon RC, Pickering J, McCullen M, Northrop M, Pawley S, et al. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J Clin Invest 1998; 102: 538-549.
35. Hartley DP, Kolaja KL, Reichard J, Petersen DR. 4-Hydroxynonenal and malondialdehyde hepatic protein adducts in rats treated with carbon tetrachloride: immunochemical detection and lobular localization. Toxicol Appl Pharmacol 1999; 161: 23-33.
36. Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, et al. CB1 cannabinoid receptor antagonism: a new strategy for the treatment of liver fibrosis. Nat Med 2006; 12: 671-676.
37. Llovet JM, Bartolí R, Planas R, Cabré E, Jimenez M, Urban A, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 1994; 35: 1648-1652.
38. Vassalli P. The pathophysiology of tumor necrosis factors. Ann Rev Immunol 1992; 10: 411-452.